In vitro evaluation of cefepime and other broad-spectrum β-lactams for isolates in Malaysia and Singapore medical centers
- 31 December 1999
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 35 (4) , 277-283
- https://doi.org/10.1016/s0732-8893(99)00098-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the etest methodDiagnostic Microbiology and Infectious Disease, 1997
- A Randomized, Double-blind Clinical Trial Comparing Cefepime Plus Metronidazole With Imipenem-Cilastatin in the Treatment of Complicated Intra-abdominal InfectionsArchives of Surgery, 1997
- Cefepime/Amikacin Versus Ceftazidime/Amikacin as Empirical Therapy for Febrile Episodes in Neutropenic Patients: A Comparative StudyClinical Infectious Diseases, 1997
- Is it important to identify extended-spectrum beta-lactamase-producing isolates?European Journal of Clinical Microbiology & Infectious Diseases, 1996
- Ceftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United StatesThe Journal of Infectious Diseases, 1994
- CefepimeDrugs, 1994
- A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive careJournal of Antimicrobial Chemotherapy, 1993
- Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patientsJournal of Antimicrobial Chemotherapy, 1993
- Factors involved in the enhanced efficacy against Gram-negative bacteria of fourth generation cephalosporinsJournal of Antimicrobial Chemotherapy, 1992
- Evaluation of the E test, a novel method of quantifying antimicrobial activityJournal of Antimicrobial Chemotherapy, 1991